Please login to the form below
mXm
This page shows the latest mXm news and features for those working in and with pharma, biotech and healthcare.
mXm launches mXm Health Consulting
Strategic consulting arm to operate alongside mXm Medical Communications. mXm Group has launched a new strategic consulting services arm - mXm Health Consulting - as a result of “growing business needs”. ... Peter Dommett, mXm Group's managing
Latest news
-
Finalists revealed for Communiqué Awards 2016
for Janssen. Expert Seminars In Psychopharmacology: Schizophrenia. by mXm Medical Communications and Arbor Scientia Inc.
-
The right agenda
Post-meeting evaluation. Peter Dommett, MD of mXm Medical Communications provides guidance to effective post-meeting evaluation in Instant Expert on page 21 of Meetings and Venues 2008.
-
Organising effective meetings
The Authors. Peter Dommett is the managing director and Dr Kristin Pagano is the medical director at mXm Medical Communications.
-
Communiqué Awards 2008: Results
Best International PR Campaign. Sponsored by Hanson Search. WINNER:. Agency:mXm Medical Communications. ... Agency:mXm Medical Communications. Client:UCB Pharma SA and the International Bureau for Epilepsy.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
‘Flexible working’: fashionable buzzword or fundamental business operation?
Can flexible working go a long way to fulfilling everyone’s personal and business goals?
-
Improving NHS sustainability through service redesign partnerships and effective communications
Peter Dommett is managing director of mXm Group and Jacqui Lyttle is strategic consultant of mXm Health Consulting.
-
Meetings
Peter Dommett is managing director of mXm Group, mxmcommunications.com.
-
Is ‘value’ in the eye of the beholder?
Peter Dommett is managing director mXm Group.
More from intelligence
Approximately 3 fully matching, plus 1 partially matching documents found.
Latest appointments
-
mXm Group bolsters its editorial and account handing teams
The mXm account handling team has been strengthened with the addition of Tony Cornell as event director. ... with solid relevant experience from other respected organisations and raw young talent which can grow and thrive within the supportive mXm
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their agency.With many years’ experience in the pharmaceutical industry – domestic, international,
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- World Health Organization releases new road map for breast cancer
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Making new year resolutions that can also benefit others
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- Omnichannel communications in Medical Affairs: closing the gap between aspiration and reality
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Meeting healthcare’s rising challenges
- Why female mentorship is so powerful in pharma
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
